Non-interventional Study to Collect Real-world Clinical and Patient-reported Outcomes in Ovarian Cancer

Inclusion Criteria:

1. Signed written informed consent

2. Women aged ≥ 18 years

3. Newly diagnosed with primary advanced (FIGO stages III and IV) high-grade epithelialovarian cancer (including fallopian tube and/or primary peritoneal cancer)

4. For patients who qualify for primary debulking surgery, all surgical procedures mustbe completed prior to enrollment

5. BRCA mutation test (routinely analyzed germline and/or somatic BRCA1/2 status aloneor as part of HRD status determination) already performed or initiated/intended

6. First-line platinum-based chemotherapy planned or a maximum of 3 cycles alreadyreceived with no sign of disease progression. Total number of cycles afterenrollment should be decided individually for each single patient by the treatingphysician. In case of neoadjuvant chemotherapy and interval debulking surgery, thepatient should be enrolled after completion of surgical procedure and at the time ofthe 1st post-surgery cycle of platinum-based chemotherapy.

7. Willing and able to report PROs electronically

8. Women of childbearing potential must use two forms of reliable contraceptionaccording to standard of care

Exclusion Criteria:

1. Pregnancy or breast-feeding 2. Current or planned participation in an interventionalclinical trial on first-line treatment of OC 3. Current or upcoming systemictreatment of any tumor other than OC 4. Not eligible for platinum-based chemotherapyor early progress during the cycles of first-line platinum-based chemotherapy priorto enrollment